{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:18:32Z","timestamp":1788175112705,"version":"build-2803163510"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Health and Labour Sciences Research","award":["24FE1003"],"award-info":[{"award-number":["24FE1003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess pregnancy and neonatal outcomes in women with rheumatoid arthritis treated with an etanercept biosimilar, and to provide real-world safety evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective, single-centre study included 11 pregnant women with rheumatoid arthritis who received an etanercept biosimilar at the National Center for Child Health and Development (Tokyo) between October 2018 and March 2022. The clinical characteristics, disease activity, medications, delivery outcomes, and neonatal health were reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All 11 pregnancies were live births. The median maternal age was 34\u00a0years, the gestational age at delivery was 39.7\u00a0weeks, and the birth weight was 2929\u00a0g. One preterm birth (9.1%) and two caesarean deliveries (18.2%) occurred. No cases of low birth weight or neonatal intensive care unit admission were reported. One case of patent foramen ovale was noted. All neonates had 5-minute Apgar scores of \u22659. The etanercept biosimilar was discontinued before delivery in four cases to allow for infant vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Use of the etanercept biosimilar during pregnancy was associated with favourable outcomes, supporting its safety and utility in managing rheumatoid arthritis during pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/mr\/roag021","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:52:15Z","timestamp":1772628735000},"page":"747-752","source":"Crossref","is-referenced-by-count":0,"title":["A case series of rheumatoid arthritis patients exposed to an etanercept biosimilar during pregnancy: Evidence from an increasingly accepted treatment option"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8031-7718","authenticated-orcid":false,"given":"Ayako","family":"Kitada","sequence":"first","affiliation":[{"name":"Division of Maternal Medicine, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development , Tokyo ,","place":["Japan"]},{"name":"Department of Rheumatology, Institute of Medicine, University of Tsukuba , Tsukuba ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinatsu","family":"Takai","sequence":"additional","affiliation":[{"name":"Division of Maternal Medicine, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5506-3787","authenticated-orcid":false,"given":"Akitsu","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Division of Maternal Medicine, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Miyagawa","sequence":"additional","affiliation":[{"name":"Division of Maternal Medicine, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Division of Obstetrics, Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Division of Obstetrics, Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagayoshi","family":"Umehara","sequence":"additional","affiliation":[{"name":"Division of Obstetrics, Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Murashima","sequence":"additional","affiliation":[{"name":"Division of Maternal Medicine, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development , Tokyo ,","place":["Japan"]},{"name":"Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University , Saitama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3411-5896","authenticated-orcid":false,"given":"Kayoko","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Division of Maternal Medicine, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"2026083106413584600_ref1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/1756-185X.12998","article-title":"The age at onset of rheumatoid arthritis is increasing in Japan: a nationwide database study","volume":"20","author":"Kato","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"2026083106413584600_ref2","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1136\/annrheumdis-2014-205383","article-title":"Fertility in women with rheumatoid arthritis: influence of disease activity and medication","volume":"74","author":"Brouwer","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2026083106413584600_ref3","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1186\/s12884-023-06033-2","article-title":"Association between disease activity of rheumatoid arthritis and maternal and fetal outcomes in pregnant women: a systematic review and meta-analysis","volume":"23","author":"Lv","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"2026083106413584600_ref4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/mr\/roae026","article-title":"Systematic review for the treatment of older rheumatoid arthritis patients informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis","volume":"34","author":"Sugihara","year":"2024","journal-title":"Mod Rheumatol"},{"key":"2026083106413584600_ref5","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/acr.25117","article-title":"2022 American College of Rheumatology Guideline for exercise, rehabilitation, diet, and additional integrative interventions for rheumatoid arthritis","volume":"75","author":"England","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026083106413584600_ref6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2026083106413584600_ref7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology Guideline for the Management of Reproductive Health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2026083106413584600_ref8","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","article-title":"British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids","volume":"62","author":"Russell","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2026083106413584600_ref9","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","article-title":"EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update","volume":"84","author":"R\u00fcegg","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"2026083106413584600_ref10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1136\/annrheumdis-2017-212196","article-title":"Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study","volume":"77","author":"Mariette","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2026083106413584600_ref11","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1136\/ard.2008.105924","article-title":"Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant\u2019s serum","volume":"68","author":"Murashima","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2026083106413584600_ref12","doi-asserted-by":"publisher","first-page":"e00795","DOI":"10.14309\/ctg.0000000000000795","article-title":"Use of biosimilars to infliximab during pregnancy in women with inflammatory bowel disease: results from the pregnancy in inflammatory bowel disease and neonatal outcomes (PIANO) study","volume":"15","author":"Long","year":"2024","journal-title":"Clin Transl Gastroenterol"},{"key":"2026083106413584600_ref13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.14735\/amgh201820","article-title":"Pregnancy outcomes in women with inflammatory bowel disease treated with biosimilar infliximab","volume":"72","author":"Kolar","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"2026083106413584600_ref14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/1753495X211028779","article-title":"Outcomes following biosimilar TNF inhibitor use for inflammatory-mediated immune disorders in pregnancy","volume":"15","author":"Scott","year":"2022","journal-title":"Obstet Med"},{"key":"2026083106413584600_ref15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3904\/kjim.2021.339","article-title":"Incidence and prevalence of seropositive rheumatoid arthritis among Korean women of childbearing age: a nationwide population-based study","volume":"38","author":"Chung","year":"2023","journal-title":"Korean J Intern Med"},{"key":"2026083106413584600_ref16","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3109\/14397595.2016.1140256","article-title":"Tocilizumab and pregnancy: four cases of pregnancy in young women with rheumatoid arthritis refractory to anti-TNF biologics with exposure to tocilizumab","volume":"26","author":"Kaneko","year":"2016","journal-title":"Mod Rheumatol"},{"key":"2026083106413584600_ref17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/RHU.0000000000001935","article-title":"Pregnancy outcomes in women with rheumatoid arthritis: a systematic review and meta-analysis","volume":"29","author":"Sim","year":"2023","journal-title":"J Clin Rheumatol"},{"key":"2026083106413584600_ref18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2020-219547","article-title":"Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study","volume":"80","author":"Smeele","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2026083106413584600_ref19","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1136\/ard-2022-222679","article-title":"Tumour necrosis factor inhibitor use during pregnancy is associated with increased birth weight of rheumatoid arthritis patients\u2019 offspring","volume":"81","author":"Smeele","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2026083106413584600_ref20","doi-asserted-by":"publisher","first-page":"887462","DOI":"10.3389\/fphar.2022.887462","article-title":"Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis","volume":"13","author":"Gerardi","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026083106413584600_ref21","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1093\/rheumatology\/keaa064","article-title":"Maternal and neonatal outcomes associated with biologic exposure before and during pregnancy in women with inflammatory systemic diseases: a systematic review and meta-analysis of observational studies","volume":"59","author":"Tsao","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2026083106413584600_ref22","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/1471-0528.17093","article-title":"Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: a systematic review and meta-analysis","volume":"129","author":"O\u2019Byrne","year":"2022","journal-title":"BJOG."},{"key":"2026083106413584600_ref23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cgh.2020.09.021","article-title":"Biologics for inflammatory bowel disease and their safety in pregnancy: a systematic review and meta-analysis","volume":"20","author":"Nielsen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026083106413584600_ref24","doi-asserted-by":"publisher","first-page":"e059203","DOI":"10.1136\/bmjopen-2021-059203","article-title":"Fetal-neonatal and maternal pregnancy outcomes in women with rheumatoid arthritis: a population-based cohort study","volume":"12","author":"Tsai","year":"2022","journal-title":"BMJ Open"},{"key":"2026083106413584600_ref25","volume-title":"Guidelines for the Management of Rheumatoid Arthritis 2024","author":"Japan College of Rheumatology, editor","year":"2024","edition":"Revised"},{"key":"2026083106413584600_ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-059203","volume-title":"Rowland and Tozer\u2019s Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications","author":"Derendorf","year":"2019","edition":"5th edn"},{"key":"2026083106413584600_ref27","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3389\/fimmu.2017.01123","article-title":"Immunological changes in blood of newborns exposed to anti-TNF-\u03b1 during pregnancy","volume":"8","author":"Esteve-Sol\u00e9","year":"2017","journal-title":"Front Immunol"},{"key":"2026083106413584600_ref28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/art.42386","article-title":"2022 American College of Rheumatology Guideline for vaccinations in patients with rheumatic and musculoskeletal diseases","volume":"75","author":"Bass","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2026083106413584600_ref29","doi-asserted-by":"publisher","DOI":"10.1002\/art.42386","volume-title":"Guideline for Vaccination in Immunocompromised Patients 2024","author":"Japan Pediatric Infectious Disease Society, editor","year":"2024"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roag021\/67256744\/roag021.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/36\/5\/747\/67256744\/roag021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/36\/5\/747\/67256744\/roag021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:41:47Z","timestamp":1788172907000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/36\/5\/747\/8509086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,6]]},"published-print":{"date-parts":[[2026,8,31]]}},"URL":"https:\/\/doi.org\/10.1093\/mr\/roag021","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,3,6]]}}}